HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inhibition of 5'-deoxy-5-fluorouridine phosphorolysis by acyclothymidine in tumor cell homogenates.

Abstract
The inhibitory effect of acyclothymidine[AcyT, 5-methyl-1-(2'-hydroxyethoxymethyl) uracil], a potent pyrimidine nucleoside phosphorylase (PyNPase) inhibitor, on 5'-deoxy-5-fluorouridine (5'-DFUR) phosphorolysis in human and mouse tumor cell homogenates was measured. Competitive inhibition was observed in MKN-74 and Lewis lung carcinoma (LLC), whereas non-competitive inhibition was observed in HeLa. The strength of the inhibitory effect by AcyT showed the following pattern: HeLa < human normal intestine < mouse normal intestine < Colon 26 < LLC < MKN-74 < DLD-1. From the kinetic parameter obtained, we simulated the inhibitory effect of AcyT on 5'-DFUR phosphorolysis in tumor cells and the intestine. These data indicated that AcyT was more sensitive in normal mouse intestine than in Colon 26 and LLC, and that orally administered AcyT can reduce the intestinal toxicity of 5'-DFUR without reducing the antitumor effect in the mouse. The present finding may have an important implication for attempts to introduce AcyT, a potent PyNPase inhibitor, into the clinic.
AuthorsA Hamada, M Nakano, S Shimidzu, T Hasegawa, T Kawaguchi
JournalBiological & pharmaceutical bulletin (Biol Pharm Bull) Vol. 20 Issue 8 Pg. 935-8 (Aug 1997) ISSN: 0918-6158 [Print] Japan
PMID9300147 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Enzyme Inhibitors
  • Floxuridine
  • Uracil
  • N-(2-(hydroxyethoxy)methyl)-5-methyluracil
  • Thymidine Phosphorylase
  • doxifluridine
Topics
  • Animals
  • Antineoplastic Agents (metabolism)
  • Enzyme Inhibitors (pharmacology)
  • Floxuridine (metabolism)
  • Humans
  • Kinetics
  • Mice
  • Mice, Inbred C57BL
  • Thymidine Phosphorylase (antagonists & inhibitors)
  • Tumor Cells, Cultured
  • Uracil (analogs & derivatives, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: